Laurence H. Hurley

Fondatore presso Reglagene, Inc.

Health Technology

Profilo

Laurence H.
Hurley is the founder.
He founded Cylene Pharmaceuticals, Inc. in 1997 and Reglagene, Inc. in 2016.
At Reglagene, Inc., he holds the title of Director & Chief Scientific Officer.

Posizioni attive di Laurence H. Hurley

Società	Posizione	Inizio
Reglagene, Inc. Reglagene, Inc. BiotechnologyHealth Technology Reglagene Holding, Inc. engages in the provision of biotechnology solutions. It develops epigenetic medicines that regulate cancer genes. The company was founded by Vijay Gokhale, Laurence Hurley, and Richard Austin in November 2016 and is headquartered in Tucson, AZ.	Fondatore	01/11/2016

Tutte le posizioni attive di Laurence H. Hurley

Precedenti posizioni note di Laurence H. Hurley

Società	Posizione	Fine
Cylene Pharmaceuticals, Inc. Cylene Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cylene Pharmaceuticals, Inc. discovers, develops and commercializes small molecule drugs. It develops molecule drugs to treat life-threatening diseases, with a particular emphasis in oncology. The firm drug discovery platform, STAND has delivered a diverse portfolio of drug candidates that target the multiple pathways critical for the support, maintenance of cancer cells and that address unmet medical needs with substantial markets. The company was founded in 1997 by Thomas James Farrell and Daniel Douglas Von Hoff and is headquartered in San Diego, CA.	Fondatore	-

Vedi nel dettaglio l'esperienza di Laurence H. Hurley

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Laurence H. Hurley

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	2
Cylene Pharmaceuticals, Inc. Cylene Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cylene Pharmaceuticals, Inc. discovers, develops and commercializes small molecule drugs. It develops molecule drugs to treat life-threatening diseases, with a particular emphasis in oncology. The firm drug discovery platform, STAND has delivered a diverse portfolio of drug candidates that target the multiple pathways critical for the support, maintenance of cancer cells and that address unmet medical needs with substantial markets. The company was founded in 1997 by Thomas James Farrell and Daniel Douglas Von Hoff and is headquartered in San Diego, CA.	Health Technology
Reglagene, Inc. Reglagene, Inc. BiotechnologyHealth Technology Reglagene Holding, Inc. engages in the provision of biotechnology solutions. It develops epigenetic medicines that regulate cancer genes. The company was founded by Vijay Gokhale, Laurence Hurley, and Richard Austin in November 2016 and is headquartered in Tucson, AZ.	Health Technology